Nama's AI scorecard currently rates UiPath Buy (7.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is PATH's P/E ratio?

UiPath trades at a trailing price-to-earnings ratio of 17.1.

When does PATH report earnings?

UiPath's next scheduled report is on Dec 2, 2026. Analysts expect EPS of $0.19.

What is the PATH price target?

The median analyst price target from 16 analysts is $15.00, with a range of $10.00 – $23.00.

Is PATH Shariah compliant?

Nama's AAOIFI-style screen reads UiPath as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

UiPath (PATH)

Technology · Software Infrastructure · NYSE

UiPath (PATH) is a Technology company in the Software Infrastructure industry. It has a market capitalization of $6.78B, a trailing price-to-earnings ratio of 17.1 and a free-cash-flow yield of 5.0%. Over the most recent reported fiscal year, revenue grew 12.7% and free cash flow per share grew 18.4%. Nama's AI scorecard rates it Buy, 7.8 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 7.8/10

Clearly positive, short of the top band. As of Nov 7, 2026.

Momentum

Lagging · -7.6% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-77.8%

How far the last close sits under the highest price of the past five years.

Market cap	$6.78B
Trailing P/E	17.1
Price / book	3.5
Price / sales	3.9
FCF yield	5.0%
Dividend yield	—
Gross margin	82.5%
Operating margin	8.9%
Net margin	21.0%
Revenue growth (YoY)	+12.7%
Revenue growth (3-yr annual)	+15.0%
EPS growth (YoY)	+33.3%
FCF/share growth (YoY)	+18.4%
Beta	1.0
Exchange	NYSE
Sector	Technology
Industry	Software Infrastructure

PATH earnings

Next report: Dec 2, 2026 (Q3 2027, EPS estimate $0.19). Beat the EPS estimate in 2 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2027	Sep 3, 2026	$0.15	$0.15	+0.0%	$410.26M
Q1 2027	May 28, 2026	$0.15	$0.16	-6.2%	$418.38M
Q4 2026	Mar 11, 2026	$0.30	$0.25	+20.0%	$481.11M
Q3 2026	Dec 3, 2025	$0.16	$0.15	+6.7%	$411.11M

PATH analyst price target

Median target $15.00 from 16 analysts, ranging $10.00 – $23.00.

Software Infrastructure peers

Ticker	Company	Market cap	P/E
MSFT	Microsoft	$3.94T	29.4
PLTR	Palantir Technologies	$386.44B	112.2
ORCL	Oracle	$361.97B	14.4
PANW	Palo Alto Networks	$256.86B	81.9
CRWD	CrowdStrike	$222.09B	195.4
NET	Cloudflare	$95.70B	224.0
FTNT	Fortinet	$87.31B	34.5
SNPS	Synopsys	$86.32B	32.3

Explore live PATH data on Nama Insights →

PATH FAQ

Is PATH a buy?: Nama's AI scorecard currently rates UiPath Buy (7.8 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is PATH's P/E ratio?: UiPath trades at a trailing price-to-earnings ratio of 17.1.
When does PATH report earnings?: UiPath's next scheduled report is on Dec 2, 2026. Analysts expect EPS of $0.19.
What is the PATH price target?: The median analyst price target from 16 analysts is $15.00, with a range of $10.00 – $23.00.
Is PATH Shariah compliant?: Nama's AAOIFI-style screen reads UiPath as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.